Patents by Inventor Edward McGowan

Edward McGowan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
    Patent number: 11840569
    Abstract: Polypeptides are provided that bind CD123 on a target cell and the constant domain of TCR on a T cell. The polypeptides can be used in methods for treatment of CD123 associated cancers or inflammatory conditions.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: December 12, 2023
    Assignee: Ablynx N.V.
    Inventors: Diane Van Hoorick, Annelies Roobrouck, Catelijne Stortelers, João Vieira, Edward McGowan
  • T CELL RECRUITING POLYPEPTIDES CAPABLE OF BINDING CD123 AND TCR ALPHA/BETA
    Publication number: 20200157216
    Abstract: Polypeptides are provided that bind CD123 on a target cell and the constant domain of TCR on a T cell. The polypeptides can be used in methods for treatment of CD123 associated cancers or inflammatory conditions.
    Type: Application
    Filed: November 16, 2017
    Publication date: May 21, 2020
    Applicant: Ablynx N.V.
    Inventors: Diane Van Hoorick, Annelies Roobrouck, Catelijne Stortelers, João Vieira, Edward McGowan